Infectolab - research

The New ELISpot Test: A Massive Breakthrough In The Identification Of Lyme Disease

Correctly diagnosing chronic Lyme disease is one of the most consistent problems doctors face. This unfortunate struggle is compounded by the fact that many clinics and medical professionals don’t recognize chronic Lyme as a legitimate disorder, in line with the views of the CDC (Centers for Disease Control and Prevention). Subsequently, misdiagnosis rates are high, as Lyme is consistently confused with other chronic degenerative diseases such as fibromyalgia, MS, and even other more serious complications like Parkinson’s or MND. Accurate testing tools are an important addition to the Lyme-literate doctor’s arsenal, and a new variation on the traditional ELISpot test is proving to be a major breakthrough in the diagnostic field. This test is called the LymeSpot, and it provides a much more accurate picture of where a patient stands in their battle against Lyme.

Continue reading “The New ELISpot Test: A Massive Breakthrough In The Identification Of Lyme Disease”
Infectolab - laboratory

What Role Do The IFN-gamma And IL-2 Molecules Play In The Clinical Diagnosis Of Lyme Disease?

Diagnosing Lyme disease, especially the chronic variant, can be a long and delicate process. The number of misdiagnoses is high; while this has a lot to do with the poor education and recognition of the disease and the doctors treating it, it also speaks to the insidious nature of the condition. Lyme disease often mimics the symptoms of other, more prominent degenerative disorders, leading to constant misidentification. In addition, the disease affects patients in different ways, as the prevalent symptoms are often caused by a patient’s individual immune response, not the bacteria itself. Anything that can help diagnose Lyme successfully is much appreciated by doctors on the frontline. Recently, help has been identified in the form of T-cells, specifically the IFN-gamma (also called type II interferon) and IL-2 (also called interleukin-2) molecules.

Continue reading “What Role Do The IFN-gamma And IL-2 Molecules Play In The Clinical Diagnosis Of Lyme Disease?”
Infectolab - medical insurance

Lyme Disease And Medical Insurance: All You Need To Know

Facing down medical insurance when you suffer from Lyme disease can be a scary and complicated affair. Lyme exists in a gray area of medicine, where it is acknowledged and simultaneously unacknowledged. It is also potentially a chronic condition, which means long-term treatments and numerous consultations for patients. On top of that, the treatment path, already guaranteed to be long and arduous, is not always straightforward. Lyme disease can affect patients differently depending on their constitution. Trying to organize medical insurance on top of this can be an extremely stressful affair. This article will break down everything you need to know about Lyme disease and medical insurance, and hopefully help you to feel a little more reassured.

Continue reading “Lyme Disease And Medical Insurance: All You Need To Know”
Infectolab - doctor

What To Do When Your Doctor Doesn’t Believe Your Morgellons Disease Symptoms

Unexplained symptoms suddenly cropping up is a scary prospect for most people. The first place you’d likely go to find comfort and treatment is your local doctor; millions of patients visit their physician every year to address a spectrum of worrying signs and symptoms, and most go on to find treatment. What’s even more scary than the symptoms themselves, however, is the prospect of your doctor not believing you. This can cause a whole gamut of fresh distress for patients, as the person they turn to for help in medical situations is dismissive of their worries. Take Morgellons disease, for example. This rare, unnerving condition is not medically recognized by an official body, despite many thousands of people coming forward with symptoms. So what can you do if your doctor doesn’t believe your Morgellons disease symptoms?

Continue reading “What To Do When Your Doctor Doesn’t Believe Your Morgellons Disease Symptoms”
Infectolab - testing

LymeSpot: Our Unique Diagnostic Method

When it comes to Lyme disease, one of the biggest hurdles to successful treatment is the lack of accurate testing. Diagnosis in the acute stage is relatively more simple than the chronic stage; in the former, the patient will usually present with flu-like symptoms and a bullseye rash, which is a prime indicator of Lyme. Once this distinctive symptom has been brought to a doctor’s attention, successful treatment is a matter of course. However, if the acute stage develops into the chronic stage, testing and diagnosis gets a lot more complicated. The traditional test for chronic Lyme is the ELISA and Western Blot, which tests for the presence of antibodies against borrelia burgdorferi on. However, the LymeSpot, utilized by BCA-clinic in Germany and Infectolab in the U.S., is a much more precise tool, and a better option for patients and doctors alike.

Continue reading “LymeSpot: Our Unique Diagnostic Method”